{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:33:11Z","timestamp":1791264791719,"version":"4.1.0"},"reference-count":80,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,27]]},"DOI":"10.20945\/2359-3997000000493","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:09:52Z","timestamp":1656594592000},"source":"Crossref","is-referenced-by-count":9,"title":["Central adrenal insufficiency: who, when, and how? From the evidence to the controversies \u2013 an exploratory review"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-5558","authenticated-orcid":false,"given":"Mariana Rechia","family":"Bitencourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-0301","authenticated-orcid":false,"given":"Rafael Loch","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-5524","authenticated-orcid":false,"given":"Isabela","family":"Biscotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-2130","authenticated-orcid":false,"given":"Luciani R.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20220630130941_B1","volume-title":"The Pituitary","author":"Melmed","year":"2017","unstructured":"1 Melmed S, editor. The Pituitary. 4th ed. London: Elsevier; 2017. p. 47-83; 330-396.","edition":"4th ed."},{"key":"key20220630130941_B2","volume-title":"Williams textbook of endocrinology","author":"Melmed","year":"2016","unstructured":"2 Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams textbook of endocrinology. 13th ed. London: Elsevier; 2016. p. 129-139; 178-181; 199-204; 214-231.","edition":"13th ed."},{"issue":"6","key":"key20220630130941_B3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4158\/EP161720.RA","article-title":"Evaluation and Management of Adrenal Insufficiency in Critically Ill Patients: Disease State Review","volume":"23","author":"Hamrahian","year":"2017","unstructured":"3 Hamrahian AH, Fleseriu M. Evaluation and Management of Adrenal Insufficiency in Critically Ill Patients: Disease State Review. Endocr Pract. 2017;23(6):716-25.","journal-title":"Endocr Pract"},{"key":"key20220630130941_B4","volume-title":"StatPearls [Internet]","author":"Chu","year":"2022","unstructured":"4 Chu B, Marwaha K, Sanvictores T, Ayers D. Physiology, Stress Reaction. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan."},{"issue":"1","key":"key20220630130941_B5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/07853890310017044","article-title":"Corticotropin\u2010releasing hormone (CRH) in psychiatry: from stress to psychopathology","volume":"36","author":"Claes","year":"2004","unstructured":"5 Claes S. Corticotropin\u2010releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med. 2004;36(1):50-61.","journal-title":"Ann Med"},{"issue":"4","key":"key20220630130941_B6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","unstructured":"6 Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-71.","journal-title":"J Psychosom Res"},{"key":"key20220630130941_B7","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/sj.ijo.0801278","article-title":"The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes","author":"Chrousos","year":"2000","unstructured":"7 Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord. 2000;24 Suppl 2:S50-5.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"10274","key":"key20220630130941_B8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","unstructured":"8 Husebye ES, Pearce SH, Krone NP, K\u00e4mpe O. Adrenal insufficiency. Lancet. 2021;397(10274):613-29.","journal-title":"Lancet"},{"issue":"4","key":"key20220630130941_B9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.beem.2018.03.012","article-title":"Central adrenal insufficiency in children and adolescents","volume":"32","author":"Patti","year":"2018","unstructured":"9 Patti G, Guzzeti C, Di Iorgi N, Maria Allegri AE, Napoli F, Loche S, et al. Central adrenal insufficiency in children and adolescents. Best Pract Res Clin Endocrinol Metab. 2018;32(4):425-44.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key20220630130941_B10","first-page":"650","volume-title":"Endocrinologia Cl\u00ednica","author":"Vilar","year":"2016","unstructured":"10 Vilar L, editor. Endocrinologia Cl\u00ednica. 6th ed. Rio de Janeiro: Guanabara Koogan; 2016. p. 650-75.","edition":"6th ed."},{"key":"key20220630130941_B11","first-page":"235","volume-title":"Endocrinologia B\u00e1sica e cl\u00ednica","author":"Greespan","year":"2000","unstructured":"11 Greespan FS, Strewler G. Endocrinologia B\u00e1sica e cl\u00ednica. 5th ed. Rio de Janeiro: Guanabara Koogan; 2000. p. 235-253.","edition":"5th ed."},{"key":"key20220630130941_B12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1196\/annals.1296.055","article-title":"Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders","volume":"1018","author":"Keck","year":"2004","unstructured":"12 Keck ME, Holsboer F, M\u00fcller MB. Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders. Ann N Y Acad Sci. 2004;1018:445-57.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"key20220630130941_B13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2018.03.001","article-title":"Pathophysiology of Glucocorticoid Signaling","volume":"79","author":"Vitellius","year":"2018","unstructured":"13 Vitellius G, Trabado S, Bouligand J, Delemer B, Lomb\u00e8s M. Pathophysiology of Glucocorticoid Signaling. Ann Endocrinol (Paris). 2018;79(3):98-106.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"key20220630130941_B14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.17219\/acem\/41231","article-title":"Glucocorticoid receptor polymorphism in obesity and glucose homeostasis","volume":"26","author":"Majer-\u0141obodzi\u0144ska","year":"2017","unstructured":"14 Majer-\u0141obodzi\u0144ska A, Adamiec-Mroczek J. Glucocorticoid receptor polymorphism in obesity and glucose homeostasis. Adv Clin Exp Med. 2017;26(1):143-8.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"key20220630130941_B15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","article-title":"Non-genomic Effects of Glucocorticoids: An Updated View","volume":"40","author":"Panettieri","year":"2019","unstructured":"15 Panettieri RA, Schaafsma D, Amrani Y, Koziol-White C, Ostrom R, Tliba O. Non-genomic Effects of Glucocorticoids: An Updated View. Trends Pharmacol Sci. 2019;40(1):38-49.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"key20220630130941_B16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","unstructured":"16 Regal M, P\u00e1ramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735-40.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9254","key":"key20220630130941_B17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","unstructured":"17 Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357(9254):425-31.","journal-title":"Lancet"},{"issue":"6","key":"key20220630130941_B18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-18-0530","article-title":"Secondary adrenal insufficiency and pituitary dysfunction in oral\/transdermal opioid users with non-cancer pain","volume":"179","author":"Lamprecht","year":"2018","unstructured":"18 Lamprecht A, Sorbello J, Jang C, Torpy DJ, Inder WJ. Secondary adrenal insufficiency and pituitary dysfunction in oral\/transdermal opioid users with non-cancer pain. Eur J Endocrinol. 2018;179(6):353-62.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"key20220630130941_B19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cen.13125","article-title":"Adrenal insufficiency in patients on long-term opioid analgesia","volume":"85","author":"Gibb","year":"2016","unstructured":"19 Gibb FW, Stewart A, Walker BR, Strachan MWJ. Adrenal insufficiency in patients on long-term opioid analgesia. Clin Endocrinol (Oxf). 2016;85(6):831-5.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key20220630130941_B20","first-page":"212","article-title":"Management of hypopituitarism: a perspective from the Brazilian Society of Endocrinology and Metabolism","volume":"65","author":"Garmes","year":"2021","unstructured":"20 Garmes HM, Boguszewski CL, Miranda PAC, Martins MRA, da Silva SRC, Abucham JZF, et al. Management of hypopituitarism: a perspective from the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab. 2021;65(2):212-30.","journal-title":"Arch Endocrinol Metab"},{"key":"key20220630130941_B21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000443915","article-title":"Secondary Adrenal Insufficiency: Where Is It Hidden and What Does It Look Like?","volume":"46","author":"Guaraldi","year":"2016","unstructured":"21 Guaraldi F, Karamouzis I, Berardelli R, D\u2019Angelo V, Rampino A, Zichi C, et al. Secondary Adrenal Insufficiency: Where Is It Hidden and What Does It Look Like? Front Horm Res. 2016;46:159-70.","journal-title":"Front Horm Res"},{"issue":"3","key":"key20220630130941_B22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/CCM.0000000000000046","article-title":"Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review","volume":"42","author":"Lauzier","year":"2014","unstructured":"22 Lauzier F, Turgeon AF, Boutin A, Shemilt M, C\u00f4t\u00e9 I, Lachance O, et al. Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review. Crit Care Med. 2014;42(3):712-21.","journal-title":"Crit Care Med"},{"issue":"5","key":"key20220630130941_B23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rpor.2016.06.002","article-title":"Outcome of radiotherapy for pituitary adenomas","volume":"21","author":"Sebastian","year":"2016","unstructured":"23 Sebastian P, Balakrishnan R, Yadav B, John S. Outcome of radiotherapy for pituitary adenomas. Rep Pract Oncol Radiother. 2016;21(5):466-72.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"9-10","key":"key20220630130941_B24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1159\/000506903","article-title":"Hypophysitis (Including IgG4 and Immunotherapy)","volume":"110","author":"Angelousi","year":"2020","unstructured":"24 Angelousi A, Alexandraki K, Tsoli M, Kaltsas G, Kassi E. Hypophysitis (Including IgG4 and Immunotherapy). Neuroendocrinology [Internet]. 2020;110(9-10):822-35. Available from: https:\/\/www.karger.com\/Article\/FullText\/506903","journal-title":"Neuroendocrinology [Internet]"},{"issue":"12","key":"key20220630130941_B25","doi-asserted-by":"crossref","first-page":"T331","DOI":"10.1530\/ERC-17-0358","article-title":"Endocrine side effects of cancer immunotherapy","volume":"24","author":"Cukier","year":"2017","unstructured":"25 Cukier P, Santini FC, Scaranti M, Hoff AO. Endocrine side effects of cancer immunotherapy. Endocr Relat Cancer. 2017;24(12):T331-47.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"key20220630130941_B26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens","volume":"4","author":"Barroso-Sousa","year":"2018","unstructured":"26 Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, et al. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens. JAMA Oncol [Internet]. 2018 Feb 1;4(2):173. Available from: http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2017.3064","journal-title":"JAMA Oncol [Internet]"},{"issue":"11","key":"key20220630130941_B27","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1210\/jc.2014-2476","article-title":"Central Hypoadrenalism","volume":"99","author":"Crowley","year":"2014","unstructured":"27 Crowley RK, Argese N, Tomlinson JW, Stewart PM. Central Hypoadrenalism. J Clin Endocrinol Metab [Internet]. 2014;99(11):4027-36. Available from: https:\/\/academic.oup.com\/jcem\/article-lookup\/doi\/10.1210\/jc.2014-2476","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"5","key":"key20220630130941_B28","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1530\/EJE-17-0154","article-title":"Management of Endocrine Disease: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects","volume":"177","author":"Mazziotti","year":"2017","unstructured":"28 Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, et al. Management of Endocrine Disease: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol. 2017;177(5):R231-48.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key20220630130941_B29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11102-020-01048-w","article-title":"Metabolic syndrome and its components in adult hypopituitary patients","volume":"23","author":"Abe","year":"2020","unstructured":"29 Abe SY, Dos Santos KS, Barbosa BFB, Biondo CMP, Takito D, Hayashi SK, et al. Metabolic syndrome and its components in adult hypopituitary patients. Pituitary. 2020;23(4):409-16.","journal-title":"Pituitary"},{"issue":"3","key":"key20220630130941_B30","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2004-1300","article-title":"Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations","volume":"90","author":"Vallette-Kasic","year":"2005","unstructured":"30 Vallette-Kasic S, Brue T, Pulichino AM, Gueydan M, Barlier A, David M, et al. Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab. 2005;90(3):1323-31.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20220630130941_B31","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab022","article-title":"New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays","volume":"5","author":"Javorsky","year":"2021","unstructured":"31 Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Col\u00f3n-Franco JM, et al. New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays. J Endocr Soc. 2021;5(4):bvab022.","journal-title":"J Endocr Soc"},{"issue":"11","key":"key20220630130941_B32","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","unstructured":"32 Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(11):3888-921.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key20220630130941_B33","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1210\/jc.2008-0710","article-title":"Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: A metaanalysis","volume":"93","author":"Kazlauskaite","year":"2008","unstructured":"33 Kazlauskaite R, Evans AT, Villabona CV, Abdu TAM, Ambrosi B, Atkinson AB, et al. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: A metaanalysis. J Clin Endocrinol Metab. 2008;93(11):4245-53.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20220630130941_B34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000262532","article-title":"Pitfalls in the diagnosis of central adrenal insufficiency in children","volume":"17","author":"Kazlauskaite","year":"2010","unstructured":"34 Kazlauskaite R, Maghnie M. Pitfalls in the diagnosis of central adrenal insufficiency in children. Endocr Dev. 2010;17:96-107.","journal-title":"Endocr Dev"},{"issue":"9","key":"key20220630130941_B35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1507\/endocrj.EJ18-0147","article-title":"Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis","volume":"65","author":"Ach","year":"2018","unstructured":"35 Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, et al. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis. Endocr J. 2018;65(9):935-42.","journal-title":"Endocr J"},{"issue":"5","key":"key20220630130941_B36","first-page":"338","article-title":"Insulin- and propanol-glucagon stimulation tests. Comparison of both methods","volume":"123","author":"Andler","year":"1975","unstructured":"36 Andler W, Bernasconi S, Giovanelli G, Biro G. [Insulin- and propanol-glucagon stimulation tests. Comparison of both methods]. Monatsschr Kinderheilkd. 1975;123(5):338-9.","journal-title":"Monatsschr Kinderheilkd"},{"issue":"5","key":"key20220630130941_B37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2265.1989.tb01276.x","article-title":"Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects","volume":"31","author":"Littley","year":"1989","unstructured":"37 Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol (Oxf). 1989;31(5):527-33.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key20220630130941_B38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12020-019-02094-6","article-title":"Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test","volume":"67","author":"de Vries","year":"2020","unstructured":"38 de Vries F, Lobatto DJ, Bakker LEH, van Furth WR, Biermasz NR, Pereira AM. Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test. Endocrine. 2020;67(1):161-71.","journal-title":"Endocrine"},{"issue":"5","key":"key20220630130941_B39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.1994.tb03011.x","article-title":"The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis","volume":"40","author":"Fiad","year":"1994","unstructured":"39 Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf). 1994;40(5):603-9.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key20220630130941_B40","first-page":"183","article-title":"Secondary adrenal insufficiency: From the physiopathology to the possible role of modified-release hydrocortisone treatment","volume":"43","author":"Paragliola","year":"2018","unstructured":"40 Paragliola RM, Corsello SM. Secondary adrenal insufficiency: From the physiopathology to the possible role of modified-release hydrocortisone treatment. Minerva Endocrinol [Internet]. 2018;43(2):183-97. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L622641725&from=export","journal-title":"Minerva Endocrinol [Internet]"},{"issue":"12","key":"key20220630130941_B41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrendo.2012.134","article-title":"Regulation of cortisol bioavailability--effects on hormone measurement and action","volume":"8","author":"Perogamvros","year":"2012","unstructured":"41 Perogamvros I, Ray DW, Trainer PJ. Regulation of cortisol bioavailability--effects on hormone measurement and action. Nat Rev Endocrinol. 2012;8(12):717-27.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"key20220630130941_B42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/jpem-2017-0270","article-title":"The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency","volume":"31","author":"Verbeeten","year":"2018","unstructured":"42 Verbeeten KC, Ahmet AH. The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency. J Pediatr Endocrinol Metab. 2018;31(2):107-15.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"key20220630130941_B43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0042-108071","article-title":"Corticosteroid-Binding Globulin: A Review of Basic and Clinical Advances","volume":"48","author":"Meyer","year":"2016","unstructured":"43 Meyer EJ, Nenke MA, Rankin W, Lewis JG, Torpy DJ. Corticosteroid-Binding Globulin: A Review of Basic and Clinical Advances. Horm Metab Res. 2016;48(6):359-71.","journal-title":"Horm Metab Res"},{"issue":"1","key":"key20220630130941_B44","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2014-3130","article-title":"Naturally occurring mutations of human corticosteroid-binding globulin","volume":"100","author":"Simard","year":"2015","unstructured":"44 Simard M, Hill LA, Lewis JG, Hammond GL. Naturally occurring mutations of human corticosteroid-binding globulin. J Clin Endocrinol Metab. 2015;100(1):E129-39.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key20220630130941_B45","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1210\/jc.2012-1806","article-title":"Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency","volume":"97","author":"Sayyed Kassem","year":"2012","unstructured":"45 Sayyed Kassem L, El Sibai K, Chaiban J, Abdelmannan D, Arafah BM. Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency. J Clin Endocrinol Metab. 2012;97(10):3655-62.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20220630130941_B46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4158\/EP10262.RA","article-title":"Biochemical diagnosis of adrenal insufficiency: the added value of dehydroepiandrosterone sulfate measurements","volume":"17","author":"Al-Aridi","year":"2011","unstructured":"46 Al-Aridi R, Abdelmannan D, Arafah BM. Biochemical diagnosis of adrenal insufficiency: the added value of dehydroepiandrosterone sulfate measurements. Endocr Pract. 2011;17(2):261-70.","journal-title":"Endocr Pract"},{"issue":"5","key":"key20220630130941_B47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000368318","article-title":"Central adrenal insufficiency could not be confirmed by measurement of basal serum DHEAS levels in pubertal children","volume":"82","author":"Vaiani","year":"2014","unstructured":"47 Vaiani E, Maceiras M, Chaler E, Lazzati JM, Chiavero M, Novelle C, et al. Central adrenal insufficiency could not be confirmed by measurement of basal serum DHEAS levels in pubertal children. Horm Res Paediatr [Internet]. 2014;82(5):332-7. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L600433462&from=export","journal-title":"Horm Res Paediatr [Internet]"},{"issue":"1","key":"key20220630130941_B48","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1210\/jc.2010-0692","article-title":"Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2","volume":"96","author":"Topor","year":"2011","unstructured":"48 Topor LS, Asai M, Dunn J, Majzoub JA. Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2. J Clin Endocrinol Metab. 2011;96(1):E31-9.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20220630130941_B49","first-page":"42","article-title":"Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis","volume":"7","author":"Charoensri","year":"2017","unstructured":"49 Charoensri S, Chailurkit L, Muntham D, Bunnag P. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis. J Clin Transl Endocrinol. 2017;7:42-6.","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"key20220630130941_B50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","unstructured":"50 Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, et al. Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry. J Clin Endocrinol Metab. 1991;72(1):39-45.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key20220630130941_B51","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn2914","article-title":"The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration","volume":"11","author":"Lightman","year":"2010","unstructured":"51 Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010;11(10):710-8.","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"key20220630130941_B52","first-page":"3082","article-title":"Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning","volume":"84","author":"Plat","year":"1999","unstructured":"52 Plat L, Leproult R, L\u2019Hermite-Baleriaux M, Fery F, Mockel J, Polonsky KS, et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab. 1999;84(9):3082-92.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20220630130941_B53","doi-asserted-by":"crossref","first-page":"bvaa160","DOI":"10.1210\/jendso\/bvaa160","article-title":"Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency","volume":"4","author":"Ekstrand","year":"2020","unstructured":"53 Ekstrand E, Esposito D, Ragnarsson O, Isgaard J, Johannsson G. Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency. J Endocr Soc. 2020;4(12):bvaa160.","journal-title":"J Endocr Soc"},{"issue":"10","key":"key20220630130941_B54","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","unstructured":"54 Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab. 2006;91(10):3954-61.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20220630130941_B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-16-0081","article-title":"Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency","volume":"6","author":"Quinkler","year":"2017","unstructured":"55 Quinkler M, Ekman B, Marelli C, Uddin S, Zelissen P, Murray RD. Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency. Endocr Connect. 2017;6(1):1-8.","journal-title":"Endocr Connect"},{"issue":"4","key":"key20220630130941_B56","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","unstructured":"56 Burman P, Mattsson AF, Johannsson G, H\u00f6ybye C, Holmer H, Dahlqvist P, et al. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab. 2013;98(4):1466-75.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20220630130941_B57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","unstructured":"57 Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015;100(2):407-16.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20220630130941_B58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","article-title":"Mortality in adults with hypopituitarism: a systematic review and meta-analysis","volume":"56","author":"Jasim","year":"2017","unstructured":"58 Jasim S, Alahdab F, Ahmed AT, Tamhane S, Prokop LJ, Nippoldt TB, et al. Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine. 2017;56(1):33-42.","journal-title":"Endocrine"},{"issue":"5","key":"key20220630130941_B59","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/cen.13141","article-title":"ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres","volume":"85","author":"O\u2019Reilly","year":"2016","unstructured":"59 O\u2019Reilly MW, Reulen RC, Gupta S, Thompson CA, Dineen R, Goulden EL, et al. ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres. Clin Endocrinol (Oxf). 2016;85(5):748-56.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"key20220630130941_B60","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock","year":"2009","unstructured":"60 Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab. 2009;94(11):4216-23.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20220630130941_B61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ando.2018.03.002","article-title":"Therapeutic patient education in adrenal insufficiency","volume":"79","author":"Guignat","year":"2018","unstructured":"61 Guignat L. Therapeutic patient education in adrenal insufficiency. Ann Endocrinol (Paris). 2018;79(3):167-73.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"5","key":"key20220630130941_B62","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","article-title":"Subjective health status in Norwegian patients with Addison\u2019s disease","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","unstructured":"62 L\u00f8v\u00e5s K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison\u2019s disease. Clin Endocrinol (Oxf). 2002;56(5):581-8.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"14","key":"key20220630130941_B63","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","unstructured":"63 Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 1999;341(14):1013-20.","journal-title":"N Engl J Med"},{"issue":"10","key":"key20220630130941_B64","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","article-title":"A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency","volume":"94","author":"Alkatib","year":"2009","unstructured":"64 Alkatib AA, Cosma M, Elamin MB, Erickson D, Swiglo BA, Erwin PJ, et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab. 2009;94(10):3676-81.","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"key20220630130941_B65","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.1074\/jbc.M200491200","article-title":"Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3)","volume":"277","author":"Liu","year":"2002","unstructured":"65 Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem. 2002;277(24):21379-88.","journal-title":"J Biol Chem"},{"issue":"11","key":"key20220630130941_B66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0024-3205(97)00011-8","article-title":"Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells","volume":"60","author":"Yoneyama","year":"1997","unstructured":"66 Yoneyama A, Kamiya Y, Kawaguchi M, Fujinami T. Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells. Life Sci. 1997;60(11):833-8.","journal-title":"Life Sci"},{"issue":"8","key":"key20220630130941_B67","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1210\/en.2003-0044","article-title":"Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms","volume":"144","author":"Simoncini","year":"2003","unstructured":"67 Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology. 2003;144(8):3449-55.","journal-title":"Endocrinology"},{"issue":"3","key":"key20220630130941_B68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diabetes.54.3.765","article-title":"Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women","volume":"54","author":"Dhatariya","year":"2005","unstructured":"68 Dhatariya K, Bigelow ML, Nair KS. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes. 2005;54(3):765-9.","journal-title":"Diabetes"},{"issue":"6","key":"key20220630130941_B69","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1210\/jc.2008-2636","article-title":"Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial","volume":"94","author":"Rice","year":"2009","unstructured":"69 Rice SPL, Agarwal N, Bolusani H, Newcombe R, Scanlon MF, Ludgate M, et al. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial. J Clin Endocrinol Metab. 2009;94(6):1966-72.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20220630130941_B70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2265.2007.02750.x","article-title":"Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status","volume":"66","author":"Christiansen","year":"2007","unstructured":"70 Christiansen JJ, Andersen NH, S\u00f8rensen KE, Pedersen EM, Bennett P, Andersen M, et al. Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status. Clin Endocrinol (Oxf). 2007;66(3):426-33.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"key20220630130941_B71","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline","volume":"99","author":"Wierman","year":"2014","unstructured":"71 Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(10):3489-510.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20220630130941_B72","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus Fludrocortisone for Adults with Septic Shock","volume":"378","author":"Annane","year":"2018","unstructured":"72 Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378(9):809-18.","journal-title":"N Engl J Med"},{"issue":"12","key":"key20220630130941_B73","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"43","author":"Annane","year":"2017","unstructured":"73 Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43(12):1751-63.","journal-title":"Intensive Care Med"},{"issue":"10","key":"key20220630130941_B74","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1210\/jc.2006-0674","article-title":"Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods","volume":"91","author":"Arafah","year":"2006","unstructured":"74 Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab. 2006;91(10):3725-45.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20220630130941_B75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4158\/EP-2017-0074","article-title":"Predicting recovery of the hypothalamic-pituitary-adrenal axis after prolonged glucocorticoid use","volume":"24","author":"Leong","year":"2018","unstructured":"75 Leong SH, Shander S, Ratnasingam J. Predicting recovery of the hypothalamic-pituitary-adrenal axis after prolonged glucocorticoid use. Endocr Pract. 2018;24(1):14-20.","journal-title":"Endocr Pract"},{"issue":"6","key":"key20220630130941_B76","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0004563220961745","article-title":"Hypothalamic-pituitary-adrenal axis suppression \u2013 The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery","volume":"57","author":"Kalaria","year":"2020","unstructured":"76 Kalaria T, Agarwal M, Kaur S, Hughes L, Sharrod-Cole H, Chaudhari R, et al. Hypothalamic-pituitary-adrenal axis suppression \u2013 The value of salivary cortisol and cortisone in assessing hypothalamic-pituitary-adrenal recovery. Ann Clin Biochem. 2020;57(6):456-60.","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"key20220630130941_B77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2014.09.009","article-title":"Optimal glucocorticoid replacement in adrenal insufficiency","volume":"29","author":"Oksnes","year":"2015","unstructured":"77 Oksnes M, Ross R, L\u00f8v\u00e5s K. Optimal glucocorticoid replacement in adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2015;29(1):3-15.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"key20220630130941_B78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12020-017-1512-1","article-title":"Bone safety of dual-release hydrocortisone in patients with hypopituitarism","volume":"60","author":"Frara","year":"2018","unstructured":"78 Frara S, Chiloiro S, Porcelli T, Giampietro A, Mazziotti G, De Marinis L, et al. Bone safety of dual-release hydrocortisone in patients with hypopituitarism. Endocrine. 2018;60(3):528-31.","journal-title":"Endocrine"},{"issue":"12","key":"key20220630130941_B79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006512","article-title":"Extensive Regulation of Diurnal Transcription and Metabolism by Glucocorticoids","volume":"12","author":"Weger","year":"2016","unstructured":"79 Weger BD, Weger M, G\u00f6rling B, Schink A, Gobet C, Keime C, et al. Extensive Regulation of Diurnal Transcription and Metabolism by Glucocorticoids. PLoS Genet. 2016;12(12):e1006512.","journal-title":"PLoS Genet"},{"key":"key20220630130941_B80","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ebiom.2018.09.024","article-title":"Glucocorticoid deficiency causes transcriptional and post-transcriptional reprogramming of glutamine metabolism","volume":"36","author":"Weger","year":"2018","unstructured":"80 Weger M, Weger BD, G\u00f6rling B, Poschet G, Yildiz M, Hell R, et al. Glucocorticoid deficiency causes transcriptional and post-transcriptional reprogramming of glutamine metabolism. EBioMedicine. 2018;36:376-89.","journal-title":"EBioMedicine"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:10:47Z","timestamp":1656594647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/central-adrenal-insufficiency-who-when-and-how-from-the-evidence-to-the-controversies-an-exploratory-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":80,"alternative-id":["10.20945\/2359-3997000000493"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000493","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]}}}